SCHEMBL1097334

SCHEMBL1097334

CCC(F)(F)C(=O)OCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9618300 0.79 CES2 (0.32)
SCHEMBL11630550 0.79 ALDH1A1 (0.33)
SCHEMBL27305106 0.78
SCHEMBL1895685 0.77
SCHEMBL1583583 0.77
SCHEMBL1144196 0.75
SCHEMBL1681615 0.75 CYP4F2 (0.44)
SCHEMBL27382350 0.74 MEN1 (0.30)
SCHEMBL11475136 0.74 CYP4F2 (0.38)
SCHEMBL2325636 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104755473-B 2,3 benzodiazepine * 拜耳医药股份有限公司 2017-03-08 CN disclosed
CN-104755473-A 2,3-benzodiazepines Bayer Pharma AG 2015-07-01 CN disclosed
US-8153808-B2 Dihydropyridone amides as P2X7 modulators ROCHE PALO ALTO LLC (US) 2012-04-10 US disclosed
EP-2382192-A2 DIHYDROPYRIDONE AMIDES USEFUL AS MEDICAMENTS FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES F. Hoffmann-La Roche AG (CH) 2011-11-02 EP disclosed
WO-2010072647-A2 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2010-07-01 WO disclosed
US-20100160387-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed
EP-0245230-A1 Substituted 2,6-substituted pyridine compounds Monsanto Company (US) 1987-11-11 EP disclosed